ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

HHS Appoints 13 To Genetics Committee

January 17, 2003

NCI Proposes Moving Organ Systems coordinating Center Activities In House, Dispersing Grants

October 16, 1987

NCI Boosts Funding For Cooperative Groups by $25 Million, Cuts Overall Accrual by 20 Percent, to 20,000 Patients

November 11, 2011

In Brief: Durant To Leave Alabama, Will Become President, Chief Executive Officer At Fox Chase Cancer Center

September 17, 1982

(8-page issue).

January 31, 2003

Seven Organizations To Use NCI-Army Coding System.

September 1, 2000